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Abstract: Brucella spp. are Gram negative intracellular bacteria responsible for brucellosis, a 
worldwide distributed zoonosis. A prominent aspect of the Brucella life cycle is its ability to invade, 
survive and multiply within host cells. Comprehensive approaches, such as proteomics, have aided 
in unravelling the molecular mechanisms underlying Brucella pathogenesis. Technological and 
methodological advancements such as increased instrument performance and multiplexed 
quantification have broadened the range of proteome studies, enabling new and improved analyses, 
providing deeper and more accurate proteome coverage. Indeed, proteomics has demonstrated its 
contribution to key research questions in Brucella biology, i.e., immunodominant proteins, host-cell 
interaction, stress response, antibiotic targets and resistance, protein secretion. Here, we review the 
proteomics of Brucella with a focus on more recent works and novel findings, ranging from 
reconfiguration of the intracellular bacterial proteome and studies on proteomic profiles of Brucella 
infected tissues, to the identification of Brucella extracellular proteins with putative roles in cell 
signaling and pathogenesis. In conclusion, proteomics has yielded copious new candidates and 
hypotheses that require future verification. It is expected that proteomics will continue to be an 
invaluable tool for Brucella and applications will further extend to the currently ill-explored aspects 
including, among others, protein processing and post-translational modification.  




Brucella spp. are intracellular Gram-negative pathogens that cause brucellosis, a worldwide 
distributed infectious disease affecting economically important domestic mammals, wild mammals, 
and humans. Animals are infected mainly by ingestion of food or water contaminated by infected 
tissues such as aborted feti or fetal membranes. Human infection generally proceeds via direct contact 
with blood or tissues from infected animals or by consumption of contaminated dairy products, such 
as unpasteurized milk and cheese. Brucellosis in animals causes sterility and abortion, resulting in 
substantial economic losses. In humans, the disease is characterized by high undulating fever in the 
acute phase, followed by a chronic phase that might affect most organs with manifestations like 
arthritis, orchitis, hepatitis, encephalomyelitis, and endocarditis. Brucellosis remains endemic in 
many developing countries in the Middle East, Asia, Africa, and South America, where domestic 
livestock screening and vaccination programs fail to control and eradicate the disease [1–3].  
The genus Brucella currently comprises 12 species and 646 genome assemblies publicly available 
at NCBI repositories. B. suis (pigs), B. abortus (cattle) and B. melitensis (goats) are the most pathogenic 
species in humans and have been identified as potential agents of bioterrorism [4]. Brucella virulence 
does not rely on classic virulence factors such as exotoxins, flagella, and capsule. Instead, bacterial 
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pathogenesis largely depends on the ability of Brucella to trigger virulence mechanisms and adapt 
their physiology to the changing environments encountered upon interaction with the host and 
during the intracellular phases. In this context, one of the key players in Brucella virulence is the type 
IV secretion system (VirB), a macromolecular complex spanning the outer and inner membranes of 
Brucella, required for virulence in a murine model of chronic brucellosis and for intracellular 
replication in host cell models [5–7]. The VirB system is engaged in the delivery of effector proteins 
into the host cell cytosol, contributing to the control of the intracellular lifestyle of Brucella [8–13]. 
Proteomes are defined as the collection of all proteins expressed by a cell type, tissue, organism, 
etc. Opposite to genomes, proteomes are highly dynamic as proteins are continuously produced, 
modified, and degraded, depending largely on the physiological conditions and environmental 
stimuli. Comparative proteomics, combined with genomics and transcriptomics, has proved to be 
more powerful and has become more popular than classical biochemical methods like In Vivo 
Expression Technology (IVET) [14] and Signature-Tagged Mutagenesis (STM) [15] for the 
identification of virulence factors and proteins that contribute to the pathogenesis. In the last two 
decades, microbiology has benefited from mass spectrometry-based proteomics to characterize the 
molecular basis of pathogen–host relationships [16–18].  
B. melitensis was the first Brucella species to be sequenced and the genome became publicly 
available in 2002 [19]. After completion of the genome sequence, the first proteomic maps were 
obtained for B. melitensis 16M and Rev1 [20,21]. These pioneer proteomic analyses were aimed at 
providing reference maps for identification of proteins associated to host specificity, virulence, 
metabolic pathways, and antigenicity. In the following years, proteome studies became more popular 
and have addressed central topics in brucellosis research. This review will focus on the contribution 
of proteomics to the identification of novel virulence factors, to study the interaction with the host 
cell as well as the bacterial responses to environmental stresses. Additionally, we will provide a 
perspective on the contribution of mass spectrometry-based proteomics to study the subcellular 
localization of individual proteins and to support the development of better vaccines and diagnostic 
methods in brucellosis. 
2. Proteomics Technologies and Their Use for Brucella 
In the last 20 years, proteomics has been developed at a formidable pace and applied to many 
areas of Brucella research. In the beginning, protein separation by two-dimensional electrophoresis 
(2-DE), manual spot excision and protein identification by MALDI-TOF (-/TOF) was the method of 
choice. The earliest works, describing proteomes of different strains and species, though with low 
coverage, were reviewed in 2002 [19]. With the maturation and improvement of LC-MS-based 
methods, their use has become more popular and is advantageous for very basic and hydrophobic 
proteins. Furthermore, LC-MS-based proteomics avoids the technically challenging IEF step of 2D-
PAGE and is very versatile regarding sample pre-treatment and fractionation. These advantages 
translate to a higher number of identified and quantified proteins. Numerous label-using and label-
free, MS-based quantification methods have become available. The important features of employed 
methods and their individual merits have been reviewed extensively in 2012 [22]. Concomitant with 
analysis techniques, MS data analysis software has matured in the last years [23], now offering robust, 
label-free quantification and multiplexing of up to 10 samples [24] in one MS run. Since 2012, some 
of these technological advances have been implemented, yet traditional methods have remained 
popular in Brucella proteomics. There have been frequent uses of 2D-PAGE and MALDI-TOF (-TOF) 
[25–30], sometimes utilizing DIGE to minimize gel-to-gel variation [31,32] or other fluorescent dyes 
for extended dynamic range [33]. Additionally, the unusual combination of 2D-PAGE with LC-
MS/MS has been reported [34]. The multiplexing of samples and the MS/MS-based quantification of 
iTRAQ reporter ions [35,36], or alternatively with Isotope Coded Protein Labeling (ICPL) [32] has 
been pursued. In-solution digestion [37–41], or in-gel digestion [42,43], and LC-MS/MS were 
sometimes employed.  
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3. Proteomics-based Detection of Brucella spp. Immunodominant Proteins  
Immunoproteomics is one of the most common proteomics-based techniques used to identify 
antigens of potential interest mainly for serodiagnosis and vaccine development. Typically, this 
technique is based on the fractionation of complex protein samples by 2-DE according to their 
isoelectric point and molecular mass. After this separation, Western blots with reactive sera are used 
to detect the immunoreactive proteins, which are then excised from the gel, processed, and identified 
by mass spectrometry techniques.  
Traditionally, the diagnosis of brucellosis has mainly been based on the detection of anti-smooth 
LPS (S-LPS) antibodies that induce a very powerful antibody response [44–46]. However, an 
important limitation to this diagnostic method is cross-reactivity with other Gram negative bacteria 
such as Yersinia enterocolitica O:9, Escherichia coli O157, Salmonella typhimurium, and Vibrio cholera, that 
share high structural similarity with the O polysaccharide epitope of the S-LPS molecule [47–49]. 
Hence, identification of specific immunogenic proteins for the development of LPS-free and protein-
based diagnostic methods became a central subject in the brucellosis research of about a decade ago.  
Another application of immunoproteomics is discovery of novel antigen candidates for vaccine 
design. Brucellosis control and eradication programs largely depend on vaccines, which have been 
successfully used worldwide for decades. Three vaccines are used in animals: B. abortus S19 and RB51, 
and B. melitensis Rev.1 [50–52]. They provide effective protection against infection and abortion in 
animals. However, they exhibit residual human virulence and cannot be used in gravid female 
animals. Therefore, much effort has been undertaken for the development of safer and more effective 
subunit vaccines. Several Brucella cell surface and intracellular components have been evaluated as 
protective antigens [53–56]. Significant activity has been identified for only a few antigens. However, 
they elicited a poor immunogenic response and protection after Brucella infection. 
Consequently, several proteomic studies were initiated to collect an inventory of Brucella 
immunogenic proteins to be used in serodiagnosis and vaccine development (Table 1). The first 
studies identified six and eighteen immunodominant proteins in B. abortus 1119-3 and B. abortus 2308, 
respectively. Al Dahouk and collaborators aimed at identifying novel B. abortus 1119-3 antigens to be 
used in brucellosis serodiagnosis [45]. The study used 2-DE and Western blots with a rabbit 
hyperimmune serum for detection of immunodominant spots in B. abortus 1119-3 whole cell samples. 
Immunogenic spots were assigned to proteins: Cu–Zn SOD, BCSP31, ribosomal protein L7/L12, 
GroEL, GroES, and DnaK. In a similar approach, Connolly and collaborators [57] sought to identify 
candidate proteins for developing vaccines against Brucella infection in humans and cattle. To achieve 
this, they first identified one hundred and sixty-three proteins in the cell envelope of B. abortus 2308 
by 2-DE with MALDI-TOF MS and LC-MS/MS. Several new immunogenic proteins such as fumarate 
reductase flavoprotein subunit, F0F1-type ATP synthase alpha subunit and cysteine synthase A were 
identified after 2-DE and Western blot analyses probed with antisera from bovine and human 
infected with Brucella (Figure 1). A few years later, the first profiles of B. melitensis immunogenic 
proteins were obtained. Immunoreactive protein spots from whole cell and membrane proteins from 
B. melitensis M5 were identified by Western blotting with bovine, anti-Brucella-positive sera and were 
assigned to 61 proteins by mass spectrometry [58]. Many proteins such as elongation factor G, F0F1 
ATP synthase subunit beta, and OMP1were identified for the first time as immunoreactive in Brucella 
and provided novel candidates for vaccine development. Another study by Yang and collaborators 
described a similar immunoproteomic approach for the development of a brucellosis subunit vaccine 
[59]. This study identified eleven immunogenic proteins from the total soluble proteome of B. 
melitensis 16M. In 2012, Pajuaba and collaborators used immunoproteomics as a tool to identify 
antigenic proteins from B. abortus S19 that allowed efficient discrimination between infected and 
vaccinated cattle [60]. In this study, five B. abortus S19 proteins (Invasion protein B, Sod, Dps, Ndk, 
and Bfr) related with antigenicity in naturally infected cattle were identified. In an attempt to analyze 
time course-dependent immunogenicity against B. abortus 544, 2-DE and immunoblotting with sera 
from mice infected at early, middle and later times post-infection followed by MALDI-TOF MS, 
allowed identification of seventeen immunodominant proteins [61]. In order to identify new 
candidate antigens from B. abortus RB51, a rough mutant lacking the O-polysaccharide, an 
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immunoproteomics approach by 2-DE and immunoblots with sera from infected cattle was 
performed [62]. The study identified eleven immunoreactive proteins including Cu/Zn SOD, 
chaperonin DnaK, chaperonin GroES, cell-division protein FtsZ, 50s ribosomal protein L10 and 
Invasion protein B that might be helpful in reducing the cross-reactivity in brucellosis serodiagnosis. 
More recently, Wareth and collaborators analyzed whole cell immunoreactive proteins from B. 
melitensis and B. abortus field strains by probing 1D and 2-DE immunoblots with sera from naturally 
infected ruminant hosts [29,63]. Fifty-two immunodominant proteins were identified that might be 
useful in the design of alternative serological tests for detection of pan-Brucella, B. abortus- and B. 
melitensis-specific antibodies. 
4. Proteomics Strategies in the Study of Brucella-Host Cell Interaction and Stress Response 
In order to survive and establish a successful infection, intracellular bacteria need to adapt to the 
harsh conditions of the host cell. Following the entry of the pathogen into the host cell, a 
reconfiguration of the host and bacterial proteomes takes place, with bacteria producing deleterious 
virulence factors and the host triggering defense responses. In this context, mass spectrometry-based 
proteomic techniques have emerged as a valuable tool to monitor and identify bacterial virulence-
associated proteins as well as the host proteins involved in the response to the infection. This 
information has significantly improved the understanding of host–pathogen interactions during the 
cellular life cycle of pathogens, as recently reviewed [16–18,64].  
Bacterial proteomic analysis upon interaction with the host is challenging as the host proteins 
need to be efficiently isolated from the limited amounts of bacterial proteins. Some methodologies 
used to achieve this separation include differential centrifugation, immunomagnetic separation, and 
fluorescence-activated cell sorting (FACS) [16]. 
The first study reporting the proteome of B. suis recovered from infected murine macrophage-
like cells was published by Al Dahouk and collaborators in 2008 [65] (Table 2). To achieve this, a 2-D 
DIGE analysis was performed at the late stage of in vitro infection. After efficient discrimination 
between host cell and bacterial proteins, 168 proteins, which showed altered concentrations 
compared to extracellularly grown bacteria, were identified. Most of the proteins were involved in 
bacterial metabolism and were less abundant in the intracellular condition, suggesting a 
downregulation of the metabolic pathways participating in energy, nucleic acids, and protein 
metabolism. In a similar approach, murine RAW264.7 macrophages were infected with virulent B. 
abortus 2308 and the attenuated strain S19, then at different times post-infection, proteomes were 
compared in order to characterize the physiological adaptation to the intracellular lifestyle of the 
virulent strain [66]. At early times post-infection, the virulent strain downregulated metabolic and 
biosynthetic pathways and shifted to low oxygen tension type of respiration. Later, the virulent strain 
reassumed carbohydrate-based carbon utilization and protein synthesis. The attenuated strain also 
adjusted its metabolism to face intracellular conditions, but to a lesser extent. Another example of a 
comparative proteomic approach aimed at identifying B. abortus 2308 proteins, which are 
overexpressed and relevant during the intracellular phase, was performed by Roset and collaborators 
[67]. Two cyclophilins were identified as overexpressed inside host cells compared to laboratory-
grown bacteria. The study also demonstrated that these proteins are required to establish a successful 
infection. More recently, a quantitative proteomic analysis and identification of B. abortus 2308 
proteins differentially modulated in vitro and inside host macrophages was performed using iTRAQ 
isobaric tags [36]. Almost two hundred differentially abundant proteins were identified, 
undercovering the extensive rearrangement of the bacterial proteome in order to adapt to the 
intracellular microenvironment within macrophages.  
In order to analyze the changes in B. suis 1330 proteome under stress conditions, a comparative 
study of bacteria grown in anaerobiosis, microaerobiosis or aerobiosis was performed [68]. Brucella 
was shown to resist low oxygen conditions by adjusting the oxidative and non-oxidative metabolisms 
in order to maintain basic metabolic processes. This adaptation mechanism constitutes an advantage 
for survival and replication inside the restricted oxygenation environment in the host. Another 
example of proteomic analysis under stress conditions is illustrated by the study of Cui and 
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collaborators [25]. This work identified the genes regulated by the post-transcriptional regulator Hfq 
by comparing the proteomes of B. melitensis 16M wild type and the hfq mutant under stress 
conditions, known to activate Hfq regulator. As a result, 55 proteins were identified as differentially 
abundant, demonstrating the role of Hfq in coordination of the adaptive response to stress conditions. 
Recently, a label-free quantitative proteomic analysis to identify B. abortus proteins involved in 
bacterial response to distinct stresses encountered during its intracellular phase detected more than 
1000 differentially expressed proteins belonging to diverse functional groups [38].  
A few years later, several studies were initiated to address the proteome changes in the host 
upon infection with Brucella spp. A comparative proteomic approach of THP-1-derived macrophages 
infected or uninfected with B. abortus A19 was performed by Wu and collaborators [27]. At different 
times post-infection, 44 proteins showed differential abundance, highlighting the dynamic proteomic 
response to the pathogen. Lauer and collaborators used a non-gel-based quantitative iTRAQ mass 
spectrometry technique to analyze the changes in the protein expression profiles in host cell 
membrane domains as a response to exposure to rough B. melitensis VTRM1 or smooth 16 M [35]. 
This approach enabled identification of several proteins enriched or depleted in membrane domains 
engaged in Brucella internalization. More recently, a study compared proteomic profiles of bovine 
trophoblastic cells infected or uninfected with B. abortus at early times of infection [69]. This study 
provided new insights into the interaction between Brucella and trophoblastic cells as well as the 
mechanisms potentially involved in the abortion of feti in infected cattle. Finally, a recent study 
focused on protein changes in host tissues during infection. Fu and collaborators reported the 
identification of 12 proteins with significant changes in expression in mice lung tissues after infection 
via exposure to aerosolized bacteria [70].  
In order to identify proteins involved in host cell internalization, cell envelope proteins of B. 
abortus mutant strains defective in this process were separated by 2-DE and identified by MS [71]. 
Deficient internalization in the mutant strains was associated to reduced expression of outer 
membrane proteins including OMP25, OMP2b and OMP. Recently, a comparative proteomic study 
was performed to determine the role of c-di-GMP in Brucella host cell interactions. To achieve this, 
proteomic profiles of a phosphodiesterase mutant producing excess c-di-GMP and wild type B. 
melitensis 16M were compared. The analysis revealed that c-di-GMP regulates several key virulence 
processes, including cell wall and biofilm formation, nutrient acquisition, and the type IV secretion 
system [37]. 
5. Brucella Exoproteome 
The term ‘exoproteome’ refers to the protein content found in the extracellular proximity of a 
given biological system. These proteins are actively secreted to the extracellular medium or are a 
byproduct of cell lysis and protein degradation. In either way, only the most stable proteins in this 
environment will remain in abundance. Proteins present in the exoproteome, together with proteins 
that are displayed on the surface of the bacteria, such as transporters, proteases, toxins, and sensors, 
are critical for interaction with the environment, including the host cell.  
Secreted proteins usually play, among others, a role in membrane and cell wall biogenesis, 
pathogenesis, nutrient uptake, and motility. A special type of secreted proteins is contained inside 
outer membrane vesicles (OMVs). OMVs are nanoscale structures secreted by bacteria that carry 
bacterial surface antigens, small metabolites, nucleic acids, and proteins. These vesicles were shown 
to participate in the release of virulence factors such as proteases and toxins, signaling, DNA transfer 
and immunomodulation [72].  
Brucella spp. spontaneously release OMVs that contain LPS, outer membrane proteins and other 
bacterial components [73,74]. They were shown to promote internalization of B. abortus by human 
monocytes and to downregulate the immune response to favor bacterial persistence within the host 
[75]. A proteomic approach to investigate the content of B. melitensis OMVs identified mostly 
membrane proteins including outer membrane proteins OMP16, OMP19, OMP25 and OMP31, as 
well as other immunogenic proteins such as SOD and GroES [76] (Fig. 1). Additionally, the study 
demonstrated the ability of OMVs to stimulate a host cell immune response.  
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As already mentioned, VirB secretion system is a major virulence determinant of Brucella. Type 
IV secretion systems (T4SS) are involved in intracellular delivery of effector proteins that modulate 
host cell functions to promote survival an intracellular replication. Comparative, proteomic-based 
techniques have been used to identify VirB substrates and proteins affected by the expression and 
activity of this secretion system. The first study aimed at identifying proteins affected by a highly 
activated VirB system [77] by comparing proteomes of B. melitensis wild type and a virB mutant. 
MALDI-TOF-MS analysis identified differentially abundant proteins involved in diverse functional 
groups including amino acid transport and metabolism, lipid metabolism, energy production, cell 
membrane biogenesis, translation, post-translational modifications, and protein turnover. Several 
virulence-related proteins involved in intracellular survival, including VjbR, DnaK, HtrA, OMP25, 
and GntR, were down-regulated in the virB mutant. Delpino and collaborators sought to identify the 
role of VirB in the secretion of proteins to the culture medium during vegetative growth [78]. Culture 
supernatants containing extracellular proteins from B. abortus 2308 wild type (WT) and its isogenic 
virB10 mutant were harvested and subjected to 2-DE. Differential spots, present in the WT strain but 
absent in the virB10 mutant, were considered extracellular proteins secreted in a virB-dependent way 
and were identified by MALDI-TOF analysis. Eleven differential proteins were identified, including 
DnaK, choloylglycine hydrolase and a peptidyl-prolyl cis–trans isomerase. To evaluate the effect of 
VirB system on outer membrane (OM) composition, the OM proteomes from B. melitensis wild type 
and virB mutant were isolated and compared [79]. Forty-five differential proteins were identified, 
most of them comprising outer membrane proteins of the Omp25/Omp31 family. Finally, in order to 
identify proteins that are produced but cannot be secreted by VirB, B. abortus wild type and a virB 
mutant proteomes were compared looking for putative substrates and proteins subjected to T4SS 
regulation [80]. Sixty-nine differential proteins were identified after 2-DE and MALDI-TOF/TOF MS 
analysis. The majority were outer membrane and periplasmic proteins, that belonged to diverse 
functional categories.  
In a recent study, B. abortus proteins secreted into the growth medium were identified by 2-DE 
and MALDI-TOF/TOF analysis. More than twenty-seven proteins including CuZn SOD, OMPs, 
GroEL and DnaK were identified (Figure 1). Immunization of mice with culture supernatant proteins 
induced a strong humoral and cell mediated immune responses and exhibited higher protection upon 
B. abortus infection [28].  
6. Antibiotic Targets and Resistance 
The lack of effective vaccines against Brucella in humans constrains treatment of infections to 
antibiotics. Unfortunately, the ecological niche of Brucella limits the range and efficacy of antibiotics 
with the consequence of prolonged, often uncomfortable patient treatment with antibiotic 
combinations to minimize recurrence of infection. Exemplary antibiotic therapies are double 
treatments with doxycycline+streptomycin/rifampicin, or rifampicin+cotrimoxazole—even triple 
therapies like doxycycline + rifampicin + cotrimoxazole exist [81]. 
Importantly, pathogen-specific antibiotics are still sought after, prompting a search for novel, 
promising targets by employing proteomics. Here, a double strategy has been pursued over the years, 
i.e., comparative proteomics to unravel antibiotic resistance mechanisms and discovery of key 
virulence proteins that may serve as potential species-specific antibiotic targets lacking homologs in 
humans or farm animals. 
Rifampicin targets the bacterial DNA-dependent RNA polymerase and inhibits RNA 
transcription. Rifampicin resistance develops frequently, for the most part manifested as point 
mutations in the rpoB gene encoding RNA polymerase β-subunit [82]. An in vitro-generated, 
Rifampicin-resistant strain with the rpoB point mutation V154F was investigated for proteome 
changes upon exposure to rifampicin [83]. The mutant and original B. melitensis biovar abortus strain 
2308 were subjected to shotgun proteomics employing N-propionylation (12C3/13C3 label) for 
quantification. Intriguingly, rpoB gene mutations affect gene expression on a broader range in various 
bacteria, and the V154F exchange increased resistance against trimethoprim/sulfamethoxazole, too 
[83]. For the studied rpoB point mutation in Brucella, the vast majority of up-regulated (mutant vs. 
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original strain) proteins had functions in basic metabolic pathways (TCA cycle, 
glycolysis/gluconeogenesis, fatty acid synthesis and metabolism, etc.). A closer look at the cell 
envelope did not provide any obvious role for transport proteins, such as efflux pumps, in conferring 
Rifampicin resistance. An increase of an iron ion transporter and catalase suggested that Rifampicin 
elevated oxidative stress as previously observed in vivo [84].   
The strategy of subtractive genome/proteome analysis was pursued to identify potential drug 
(and vaccine) targets to treat B. abortus in humans and cattle [85]. The rationale was to single out 
potentially druggable proteins essential for B. abortus that are absent in the host organism. KAAS-
KEGG searches [86] retrieved non-homologous proteins in pathogen-specific pathways. For humans 
as well as cattle, about 40 proteins were identified that were either involved in such pathways or not 
assigned to any host metabolic pathway. Concerning drug target candidates, the authors 
intentionally focused on membrane proteins given their proven therapeutic potential. A Brucella ABC 
transporter permease was found as novel drug target in humans not being affected by any known 
compound in Drugbank, yet its functional importance remained unknown.  
Recently, the mapB gene of Brucella suis was linked to resistance against both lysozyme and the 
lipopeptide polymyxin B [40]. By combining several experimental approaches, MapB was assigned 
functions in cell envelope integrity and as TamB orthologue participating in complex with TamA in 
protein translocation across the outer membrane. To uncover substrates of MapB and affected other 
proteins, a mapB mutant was compared to the wild type with shotgun proteomics and label-free 
quantification. The mutant had diminished content of OMP31 family members and OMP25c. 
Likewise, two inner membrane proteins, an oligopeptide transporter related to β-lactam resistance, 
and a putative lipoprotein anchoring transpeptidase with putative function in peptidoglycan 
crosslinking, diminished. From collective proteome, physiological and morphological results, it 
could be concluded that MapB is not only involved in protein translocation, but is required for proper 
morphology, cell division and macrophage infection, too. 
7. Proteogenomics 
Typical shotgun proteomics workflows rely for protein identification on sequences determined 
by genomics or transcriptomics. Then again, proteome data can feed genome annotation/refinement, 
a procedure commonly named proteogenomics. This has already been done in the earlier proteome 
studies for Brucella and has gained momentum with the considerable improvement in genomics, 
proteomics, and bioinformatics over the last years. 
Already in 2006, for B. melitensis and B. abortus grown under identical lab conditions, proteomes 
were compared with the intention to discover proteome signatures explaining the preference for 
sheep and cattle as respective hosts [87]. By contrasting the Sypro Ruby-stained 2D gels, several 
importers and secretion systems (Sec, type IV and V) were found as differentially expressed. In light 
of the high genomic similarity, it appears that differences in expression (regulation) of homologous 
genes account for adaptation of the two Brucellae to their hosts.  
The utility of proteomics to improve genome data was demonstrated for the verification of 
pseudogenes and correction of translation start sites. NCBI ORF finder [88] detected possible 
alternative ORFs 200 bp up- or downstream of genes and predicted pseudogenes. In another study, 
fractionation and shotgun proteomics yielded a comprehensive set of 1729 proteins for the Brucella 
vaccine strain 104M [42]. Six novel ORFs were identified and three existing ORF models revised. 
Moreover, identification of N-terminally acetylated peptides allowed to confirm the translation 
initiation site for 29 genes. The abundance of proteins pertaining to chromosome I was significantly 
higher than chromosome II. 
8. Proteases—A Yet Untouched Topic in Proteomics for Brucella  
Surprisingly, the functional aspects of proteases in Brucellae have not been investigated with 
proteomics so far. This is in sharp contrast to the proven importance of proteases for a great many 
functions such as host infection and persistence [89–92], stress response [92–96], morphology [97], 
communication and signaling [98–100], to name the most prominent. 
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The most studied membrane-residing protease of Brucella is Lon. Lon protease contributes to the 
silencing of macrophages by modulating their cytokine response at an early infection stage [101]. It 
functions as a stress response protease and its deletion increases sensitivity to puromycin and 
hydrogen peroxide [93]. The regulatory role was recently probed by comparative RNA-seq of the 
wild type and lon strain [92]. Genes involved in stress response, quorum sensing and transcriptional 
regulation were significantly altered in Δlon strain, which substantiates the aforementioned studies. 
However, proteomics is naturally the method of choice when it comes to the discovery of protease 
targets and proteolytic processing events. In our previous works with microorganisms, Lon target 
candidates could be identified by common quantitative shotgun proteomics [102] and more 
sophisticated proteome turnover analysis [103]. There is no reason to believe why similar studies 
could not be executed in the future for Brucella to illuminate such aspects of protease function. 
An ill-characterized protease in bacteria is the rhomboid that cleaves transmembrane helices in 
the lipid bilayer. In fact, less than a handful of known or potential targets have been described, e.g., 
halocyanin [104] and tatA. After demonstrating that the B. abortus rhomboid is an active protease, we 
have carried out quantitative shotgun proteomics for B. abortus wild type and rhomboid strain 
cultivated under defined conditions. A total of 1554 proteins were identified (51.40% of B. abortus 
predicted proteome), from which 82 differed in amount. The integral membrane proteins that 
evidenced variations were considered as potential rhomboid targets. These included a lytic murein 
transglycosylase, nitrous-oxide reductase and OmpW (unpublished results).  
9. Concluding Remarks 
This work is an effort to review the relevant outcomes of proteomic-based studies in Brucella. 
Gel-based and gel-free methods have proved to be irreplaceable tools in the research of multiple 
aspects of Brucella physiology, including virulence. In recent years, throughput and accuracy of mass 
spectrometric instruments have improved, leading to a significant increase in the amount and quality 
of available proteomic data. With a large number of proteins involved in Brucella host cell interaction 
and response to stresses being identified, it is now necessary to integrate this information in a way 
that can be fully exploited by the experts in the field. Nevertheless, there remain proteome features 
underrepresented in existing Brucella studies and worth further exploration, e.g., post-translational 
modifications and protein interaction. 
Future research should focus on the identification of the novel bacteria and host cell proteins 
involved in crucial steps of the infection, such as adhesion, invasion, replication, and egress from 
cells. Differences in host specificity and virulence among the different species of Brucella also need to 
be addressed. Studies combining MS-based approaches with other “omics” techniques, like 
transcriptomics and metabolomics, will certainly allow a better understanding of pathogen-induced 
changes and immunomodulation of Brucella-infected cells and tissues. Moreover, proteomic data 
combined with genetic studies will provide valuable information on virulence gene expression and 
post-translational modifications. Proteomics future challenges in the Brucella field should be focused 
on the identification of novel virulence factors and their interconnection with classical virulence 
determinants, in order to unveil the major traits of Brucella pathogenesis, improve the detection 
methods and identify potential targets for vaccine development, all of which are crucial for the 
eradication of brucellosis. 
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Figure 1. Schematic representation of proteins identified after MS-based analyses in Brucella 
exoproteomes (secreted, non-secreted and inside OMVs) and in the cell envelope (comprising inner 
membrane, periplasm, and outer membrane). T4SS: type IV secretion system; OMVs: outer membrane 
vesicles; OMP: outer membrane protein; 2b (BAB1_0660) 25 (BAB1_0722), 16 (BAB1_1707); 19 
(BAB1_1930), 31 (BAB1_1639) GroEL: 60 kDa chaperonin (BAB2_0189); SOD: superoxide dismutase 
(Cu-Zn) (BAB2_0535); FliY: solute-binding protein/glutamate receptor: bacterial extracellular solute-
binding protein, family 3 (BAB2_0558); RbsB-2: periplasmic binding protein/LacI transcriptional 
regulator (BAB2_0377); DnaK: chaperone protein (BAB1_2129);  SurA: trigger factor-peptidyl prolyl 
cis-trans isomerase (BAB1_0917); AspC: aminotransferase (BAB1_1514); CHG: choloylglycine 
hydrolase (BAB1_1488); SerC: phosphoserine transaminase (BAB1_1699); GroES: 10 kDa chaperonin 
(BAB2_0190); IalB: invasion protein B (BAB1_0368); FtsZ: cell division protein FtsZ (BAB1_144); 
MinD: septum site-determining protein (BAB2_0883); TolB: Tol-Pal system protein (BAB1_1709); 
DnaJ: chaperone protein (BAB1_2130); SdhA: succinate dehydrogenase flavoprotein subunit 
(BAB1_1901).
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Table 1. List of proteomics-based studies for identification of immunogenic Brucella proteins. 




[45] B. abortus 1119-3 
Whole cell 
proteins 
Identification of immunogenic proteins by 2-D immunoblots probed with 




[57] B. abortus 2308 
Cell envelope 
proteins 
Detection of immunogenic proteins by 2-D Western blotting with human 








Whole cell and 
membrane 
proteins 
Identification of immunogenic proteins by 2-D immunoblotting with 
Brucella-infected bovine sera. 
MALDI-TOF MS 61 
[59] B. melitensis 16M 
Whole cell soluble 
proteins 
Identification of antigens recognized by Brucella-infected goat and human 
sera in 2-D immunoblots. 
LC–MS/MS 11 
[60] 





114 extraction  
Detection of infection markers by 1-D and 2-D immunoblots probed with 







Detection of immunodominant proteins by 2-D immunoblots probed with 
sera from experimentally infected mice. 
MALDI-TOF MS 17 
[62] B. abortus RB51 Insoluble proteins  
Analysis of immunogenic proteins by 2-DE and Western blot with sera 










Detection of antigenic proteins by SDS–PAGE and Western blotting with 
sera from naturally infected hosts (cows, buffaloes, sheep, and goats).  
MALDI-TOF MS 16 
[63] 





Identification of immunodominant proteins by 2-DE and Western blot with 
sera from naturally infected hosts (cows, buffaloes, sheep, and goats).  
MALDI-TOF MS 36 
2-DE: two-dimensional electrophoresis. 
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Table 2. MS-based proteomics studies addressing host-Brucella interactions and stress responses. 




[65] B. suis 1330 
2-D-DIGE based analysis of 
intramacrophagic proteome of B. suis at 48 
h post-infection, compared to 
extracellularly grown stationary-phase-
bacterial proteome.  
MALDI-
TOF MS 
One hundred and sixty-eight proteins with differential abundance. Most of 
the proteins identified are involved in metabolic pathways and 
downregulated intracellularly. 
[66] 
B. abortus 2308 
and S19  
Comparison of intramacrophagic 
proteomes of virulent B. abortus 2308 and 
the attenuated strain S19 at different times 
(0, 3, 20 and 44 h post-infection). 
LC MS/MS 
At early times post-infection, the virulent strain altered its respiration and 
downregulated the expression of proteins involved in metabolic and 
biosynthetic pathways. These changes are reverted to pre-infection levels at 
44 h post-infection. 
[68] B. suis 1330 
2-D-DIGE based comparative analysis of B. 
suis proteome under low oxygen conditions 
(anaerobiosis and microaerobiosis) and 
control condition (aerobiosis). 
MALDI-
TOF MS 
Upregulated glycolysis and denitrification in microaerobiosis and 
anaerobiosis.  
[71] B. abortus 1119-3 
2-DE-based proteome analysis of cell 
envelope proteins of mutant strains 
defective in internalization into host cells. 
LC-ESI-MS 
Identification of bacterial loci involved in altered expression of cell envelope 
proteins such as OMP25, OMP2b and OMP28. 
[67] B. abortus 2308 
2-DE-based comparative proteomic 
analysis of intracellular and laboratory-
grown B. abortus. 
MALDI-
TOF MS 
Two cyclophilins were identified as overexpressed during the intracellular 
phase. The double mutant strain in the genes coding for these proteins is 
attenuated in cellular and mice infection models. 
[25] B. melitensis 16M 
2-DE-based comparative proteomic 





MS identified 55 proteins with differential abundance in the mutant strain. 
These proteins belong to diverse functional groups including transport and 
metabolism, outer membrane proteins, post-translational modification and 
cellular processes. 
[27] B. abortus A19 
2-DE-based comparative proteomic 
analysis of THP-1-derived macrophages 




MS identified 44 proteins with differential abundance. These proteins were 
involved in cytoskeleton, signal transduction, energy metabolism, host 
macromolecular biosynthesis, and stress response. 
[35] 
B. melitensis 16M 
and VTRM1 
Quantitative proteomic approach to study 
protein redistribution between membrane 
domains of monocytes exposed or not 




Several proteins were distinctly enriched or depleted in membrane domains 
upon exposure to rough and smooth B. melitensis strains.  





2-D DIGE based differential proteomic 
profile of bovine chorioallantoic membrane 
explants uninfected and at early stages of 




Several proteins upregulated during infection are associated with 
modulation of the innate host immune response to infection with B. abortus, 
including proteins related to TLR signaling and ROS production, as well as 
proteins associated with inflammation and intracellular trafficking. 
[37] B. melitensis 16M 
Comparative proteomics approach to 
identify Brucella-specific proteins and 
pathways affected by changes in bacterial c-
di-GMP levels. 
LC MS/MS 
c-di-GMP levels affect multiple processes related to bacterial virulence, such 




Comparative proteomic analysis of B. 
abortus isolated within the host macrophage 





Identification of 197 differentially modulated proteins in intracellular 
Brucella. Many of them were related with iron metabolism, known to play a 




Label-free quantitative proteomic analysis 
for the identification of proteins involved in 
stress resistance. 
LC MS/MS 
Identification of over 1000 differentially abundant proteins under relevant 
stress conditions. Proteins were included in diverse functional groups such 
as oxidative phosphorylation, ABC transporters, two-component systems, 
biosynthesis of secondary metabolites, the citrate cycle, thiamine 
metabolism, and nitrogen metabolism. 
[70] B. melitesis M5 
Comparative 2-DE-based proteomic 
analysis of lung tissue of BALB/c mice 




Identification of 12 proteins differentially expressed in lung tissue during 
infection. The proteins with increased expression were related to protein 
transport, antioxidant function, and antiviral or cell activation. Proteins with 
decreased expression were related to cytoskeletal structure, enzyme 
activation, or cell intoxication and transformation.  
2-DE: two-dimensional electrophoresis.
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